We observed that monotherapy treatment of UNC0642 alone was unable to reduce tumour growth in PDX models of HCC, demonstrating that inhibiting G9a alone was insufficient in mitigating tumour progression of HCC (Fig. 5F). This evidence concerns the gene EHMT2 and neoplasm.